Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Insufficiency Following Contrast Media Administration Trial III (REMEDIAL III): Renalguard System Versus Left-ventricular End-diastolic Pressure-guided Hydration in High-risk Patients for Contrast-induced Acute Kidney Injury

NCT02489669 is registered in ClinicalTrials.gov with Clinica Mediterranea as lead sponsor.

NCT NCT02489669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02489669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Insufficiency Following Contrast Media Administration Trial III (REMEDIAL III): Renalguard System Versus Left-ventricular End-diastolic Pressure-guided Hydration in High-risk Patients for Contrast-induced Acute Kidney Injury
Lead sponsor
Clinica Mediterranea
Phase
Not applicable
Overall status
Unknown status
Start date
July 15, 2015
Completion date
December 31, 2019
Enrollment
700 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast nephropathy